Pm. Barrow et al., INFLUENCE OF DROPERIDOL ON NAUSEA AND VOMITING DURING PATIENT-CONTROLLED ANALGESIA, British Journal of Anaesthesia, 72(4), 1994, pp. 460-461
We have studied the addition of droperidol to morphine during patient-
controlled analgesia (PCA) in 57 patients using PCA after abdominal hy
sterectomy Patients in group 1 (control group) received placebo at ind
uction of anaesthesia and a PCA containing morphine, those in group 2
received droperidol 1.25 mg and a PCA containing morphine and those in
group 3 droperidol and a PCA containing droperidol 0.05 mg mg(-1) of
morphine. Patients in the control group suffered 51 episodes of nausea
compared with 35 in the droperidol bolus group and 18 in the droperid
ol PCA group (P < 0.01). in the droperidol PCA group, only 10 doses of
additional antiemetic therapy were required compared with 24 in the d
roperidol bolus group and 28 in the control group (P < 0.05). We did n
ot observe side effects attributable to droperidol. We conclude that d
roperidol added to morphine in PCA reduces nausea and antiemetic requi
rements after abdominal hysterectomy